Gilgamesh

GH Research

This pharmaceutical company develops psychedelic-based therapies for patients suffering from psychiatric and neurological disorders, including treatment-resistant depression.

Psylink

This biotechnology company develops psychedelic therapies using engineered yeast to produce plant and fungi-derived compounds for patients with treatment-resistant mental health disorders.

Small Pharma Limited

This clinical-stage biotechnology company develops psychedelic-based medicines and DMT therapies for patients with major depressive disorder and other mental health conditions.

Enabling psychedelics-assisted therapies

This biopharmaceutical company develops psychedelic-inspired medicines and a care delivery model to treat addiction for patients and healthcare providers.

Compass Pathways

This biotechnology company develops psilocybin-based therapies for patients living with treatment-resistant depression and other mental health conditions.

Mindstate Design Labs

This biotechnology company develops custom psychedelic therapeutics using an artificial intelligence platform to treat mental health conditions for patients with various psychiatric disorders.

Beckley Psytech

The company develops psychedelic-derived medicines to treat patients with neurological and psychiatric conditions such as treatment-resistant depression and rare headache disorders.

Transcend Therapeutics

This clinical-stage biotechnology company develops rapid-acting psychoactive medicines to treat patients suffering from neuropsychiatric diseases, including post-traumatic stress disorder and depression.